Targeted chromosomal genomic alterations with modified single stranded oligonucleotides

Details for Australian Patent Application No. 2001249488 (hide)

Owner University of Delaware

Inventors Rice, Michael C.; Kmiec, Eric B; Gamper, Howard B

Agent Cullen & Co

Pub. Number AU-B-2001249488

PCT Pub. Number WO01/73002

Priority 60/208,538 01.06.00 US; 60/192,179 27.03.00 US; 60/244,989 30.10.00 US; 60/192,176 27.03.00 US

Filing date 27 March 2001

Wipo publication date 8 October 2001

Acceptance publication date 8 February 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/712 (2006.01) - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose

A61K 31/7125 (2006.01) - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

8 February 2007 Application Accepted

  Published as AU-B-2001249488

1 March 2007 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 05 Feb 2007. Address for service in Australia - Cullen & Co Level 26 239 George Street Brisbane QLD 4000

29 March 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 05 Feb 2007

19 April 2007 Corrigenda

  Amendments, Section 104 - Amendments Made Under the name University of Delaware, Application No. 2001249488, delete all reference to amendments allowed.

14 June 2007 Standard Patent Sealed

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001249489

2001249487